Shanghai Allist Pharmaceuticals Co., Ltd. (SHA: 688578)

Shanghai Allist Pharmaceuticals Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jun 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	462.94	1,862	470.49	615.36	365.84	392.58
Short-Term Investments	150	230	-	20	-	-
Trading Asset Securities	2,342	419.6	1,567	1,625	2,225	554.4
Cash & Short-Term Investments	2,955	2,512	2,037	2,260	2,591	946.98
Cash Growth	-	23.29%	-9.86%	-12.78%	173.64%	636.30%
Accounts Receivable	317.99	260.17	150.85	14.83	0.29	0.63
Other Receivables	13.74	29.07	6.82	3.58	2.28	1.22
Receivables	331.73	289.24	157.68	18.42	2.57	1.85
Inventory	39.2	62.95	32.07	20.8	10.78	0.25
Prepaid Expenses	-	3.18	2.5	-	-	-
Other Current Assets	45.65	40.79	56.69	75.42	74.69	36.75
Total Current Assets	3,372	2,908	2,286	2,375	2,679	985.84
Property, Plant & Equipment	521.83	526.64	539.94	404.03	206.88	138.16
Long-Term Investments	168.72	145.26	52.73	38.37	20	110
Other Intangible Assets	65.98	66.49	68.45	67.29	69.18	68.35
Long-Term Deferred Tax Assets	-	-	11.5	-	-	-
Long-Term Deferred Charges	0.5	0.71	0.57	2.11	2.71	-
Other Long-Term Assets	825.71	729.5	482.76	243.79	8.93	26.06
Total Assets	4,954	4,376	3,442	3,130	2,987	1,328
Accounts Payable	4.98	13.25	5.15	1.75	3.44	-
Accrued Expenses	363.5	314.33	152.68	96.96	93.58	28.55
Current Portion of Long-Term Debt	-	-	-	-	-	110
Current Portion of Leases	1.04	1.43	1.66	4.72	-	-
Current Income Taxes Payable	29.3	5.4	6.98	-	0.36	0.35
Current Unearned Revenue	-	-	0.1	0.18	-	-
Other Current Liabilities	23.98	55.62	88.04	52.51	11.63	4.76
Total Current Liabilities	422.81	390.03	254.62	156.12	109.01	143.66
Long-Term Leases	0.27	0.39	0.3	0.68	-	-
Long-Term Unearned Revenue	-	-	-	-	-	0.36
Long-Term Deferred Tax Liabilities	15.42	0.14	-	-	-	-
Other Long-Term Liabilities	3.65	3.65	0.2	0.2	-	-
Total Liabilities	442.14	394.22	255.12	156.99	109.01	144.02
Common Stock	450	450	450	450	450	360
Additional Paid-In Capital	3,209	3,175	3,100	3,031	2,957	1,043
Retained Earnings	740.16	264.02	-380.16	-510.68	-528.95	-218.44
Comprensive Income & Other	113.57	93.63	17.61	3.25	-	-
Shareholders' Equity	4,512	3,982	3,187	2,973	2,878	1,184
Total Liabilities & Equity	4,954	4,376	3,442	3,130	2,987	1,328
Total Debt	1.31	1.82	1.96	5.39	-	110
Net Cash (Debt)	2,954	2,510	2,035	2,255	2,591	836.98
Net Cash Growth	-	23.32%	-9.73%	-12.99%	209.60%	23055.65%
Net Cash Per Share	6.58	5.57	4.52	4.94	7.01	2.32
Filing Date Shares Outstanding	450	450	450	450	450	360
Total Common Shares Outstanding	450	450	450	450	450	360
Working Capital	2,949	2,518	2,032	2,219	2,570	842.17
Book Value Per Share	10.03	8.85	7.08	6.61	6.40	3.29
Tangible Book Value	4,446	3,916	3,119	2,906	2,809	1,116
Tangible Book Value Per Share	9.88	8.70	6.93	6.46	6.24	3.10
Buildings	468.18	468.4	470.35	116.73	116.73	112.87
Machinery	162.26	158.55	140.27	88.34	75.36	66.24
Construction In Progress	27.91	18.58	13.8	266.57	78.44	11.44

Source: S&P Capital IQ. Standard template. Financial Sources.